Finnrick, an independent testing programme, publishes 5 assays for FSD, and all 5 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 20 May 2026.
FSD listed by Finnrick as "Not found", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/fsd.
FSD is listed as active.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 5 | 5 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from FSD's own website on 2026-08-17. Pages consulted:
FSD is listed as active and we hold 5 Finnrick assays (5 passing, 0 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 5 assays for FSD, and all 5 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 20 May 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Fusion Peptides Review, Gary Group Buy Peptides Review, GB Peptides Review.